TP53 and hepatocellular carcinoma: Elevated BFSP1 expression was significantly associated with several clinicopathological parameters, including primary tumor status, tumor stages I–III, tumor grades I–IV, histological subtype (particularly hepatocellular carcinoma), and TP53 mutation status.